ITEMS IN AFP WITH KEYWORD:
This landmark study compared active surveillance with radical prostatectomy or radiation therapy for patients with T1c or T2 prostate cancer. The benefits of active surveillance include avoiding radical therapy in one-half of the patients, with no effect on disease-specific survival or all-cause sur...
For family physicians to put PSA screening guidance into practice, they must elicit patients' preferences and provide accurate, understandable information about the benefits and harms.
This summary of the American Cancer Society Prostate Cancer Survivorship Care Guidelines provides recommended management approaches for physical and pschosocial issues facing patients after treatment.
Despite variations across guidelines, no organization recommends routine prostate-specific antigen testing to screen for prostate cancer, and most endorse decision-making between the patient and physician or no screening.
Before primary care physicians consider reintroducing the PSA test, they must have proof that it improves outcomes. The task will be to show in a future randomized study whether any PSA screening algorithm can improve survival or quality of life compared with what is now the standard of care—no routine screening.
Studies show no deaths were prevented and 1 in 5 underwent a prostate biopsy for a false-positive test. Read more.
Jan 15, 2014 Issue
AUA Releases Guideline on Early Detection of Prostate Cancer [Practice Guidelines]
In April 2013, the American Urological Association (AUA) released a guideline on early detection of prostate cancer, namely to reduce prostate cancer mortality.
Although finasteride prevents low-grade prostate tumors, it does not affect overall survival or survival after prostate cancer diagnosis. Although high-grade cancers were more common among men taking finasteride, up to 18 years of follow-up failed to show increased mortality in this group.
Patients undergoing surgery had worse urinary and sexual outcomes, whereas those undergoing external beam radiation therapy (EBRT) had worse bowel symptoms. Watchful waiting (“active surveillance”) was not the subject of this study, but given the problems associated with therapy, active surveillance...
Feb 15, 2013 Issue
Screening for Prostate Cancer: Recommendation Statement [U.S. Preventive Services Task Force]
The U.S. Preventive Services Task Force (USPSTF) recommends against prostate-specific antigen (PSA)-based screening for prostate cancer.